Although numerous studies have explored peripheral BDNF concentrations as potential biomarkers for ASD, the evidence remains conflicting and lacks consistency due to differences in analytical methods, sample processing, and clinical characteristics such as age, presence of intellectual disability (ID), or autism subtype [129,130,131,132,133]. The gene discussed is BDNF; the disease is Intellectual disability.